Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks were higher late Thursday afternoon, with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%. The iShares Biotechnology ETF (IBB) rose

MT NewswiresJun 20 16:02 ET

Kyverna Gains as FDA Clears Trial for Lead Therapy

Seeking AlphaJun 20 13:55 ET

Kyverna Therapeutics Gets FDA IND Clearance for KYV-101

By Chris Wack Kyverna Therapeutics said it has received clearance for its Investigational New Drug, or IND, application by the U.S. Food and Drug Administration for its T-cell product candidate, KYV-

WSJJun 20 09:30 ET

Express News | Kyverna Therapeutics Shares Are Trading Higher After the Company Announced KYV-101 Received FDA IND Clearance for the Treatment of Patients With Treatment-refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 Trial

BenzingaJun 20 08:56 ET

Express News | Kyverna's Kyv-101 Receives U.S. FDA Ind Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the Kysa-8 Phase 2 Trial

ReutersJun 20 08:55 ET

Sector Update: Health Care Stocks Decrease Late Afternoon

Health care stocks were softer late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) edging down 0.1%. The iShares Biotechnology ETF (IBB)

MT NewswiresJun 14 16:00 ET